Health Canada recently announced that it is exploring a regulatory pathway that would allow products containing cannabidiol (“CBD”) to be purchased without a prescription. Under the current regulatory scheme, all health...more
3/10/2025
/ Cannabidiol (CBD) oil ,
Cannabis Products ,
Clinical Trials ,
Distributors ,
Health Canada ,
Hemp ,
Pharmaceutical Industry ,
Popular ,
Prescription Drugs ,
Regulatory Agenda ,
Regulatory Requirements ,
THC
On December 28, 2024, Health Canada published a regulatory proposal in the Canada Gazette, Part I, Volume 158, Number 52, introducing amendments to the Food and Drug Regulations, CRC, c 870 and the Medical Devices...more
1/20/2025
/ Canada ,
Health Canada ,
Life Sciences ,
Medical Devices ,
Pharmaceutical Industry ,
Proposed Amendments ,
Proposed Rules ,
Public Health ,
Regulatory Agenda ,
Reporting Requirements ,
Supply Chain
On October 10, 2024, Canada’s Bill C-64, An Act respecting pharmacare (the “Pharmacare Act”) received Royal Assent. This legislation establishes a framework for a national universal pharmacare system, aiming to enhance the...more